Not Signed In -
Glimepiride |
Amaryl |
Article: Glimepiride
 | |
| Glimepiride | |
| Systematic (IUPAC) name | |
| 3-ethyl-N,N-bis (3-ethyl-4-methyl-2-oxo-5H-pyrrol-2-yl)- 4-methyl-2-oxo-5H-pyrrole-1- carboxamide | |
| Identifiers | |
| CAS number | 93479-97-1 |
| ATC code | A10BB12 |
| PubChem | 3476 |
| DrugBank | APRD00381 |
| Chemical data | |
| Formula | C24H34N4O5S |
| Mol. weight | 490.617 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | >99.5% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Glimepiride is a medium-to-long acting sulfonylurea anti-diabetic drug. It is marketed as Amaryl® by Aventis.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
| Oral antidiabetic drugs (A10B) edit |
|---|
| A10BA - Biguanide - {02-metformin} |
| A10BB - Sulfonylureas - {01-glibenclamide (glyburide)} {02-chlorpropamide} {03-tolbutamide} {05-tolazamide} {07-glipizide} {08-gliquidone} {09-gliclazide} {12-glimepiride} |
| A10BF - Alpha-glucosidase inhibitor - {01-acarbose} |
| A10BG - Thiazolidinediones (TZD) - {01-troglitazone} {02-rosiglitazone} {03-pioglitazone} |
| A10BX - Meglitinide - {02-repaglinide} {03-nateglinide} |
| no ATC - Dipeptidyl peptidase-4 (DPP-4) inhibitors - {sitagliptin} {vildagliptin} |
Categories: Pharmacology stubs | Sulfonylureas
email this page
print this page
bookmark this page
feedback on this page
